Burkina Faso vs Cote d'Ivoire: Access to anti-retroviral drugs, male
Burkina Faso
68.0%
in 2024
Cote d'Ivoire
69.0%
in 2024
Burkina Faso rank
73rd
Cote d'Ivoire rank
72nd
Access to anti-retroviral drugs, male over time
- Burkina Faso
- Cote d'Ivoire
How they compare
Cote d'Ivoire currently reports 69.0% against 68.0% in Burkina Faso, a difference of 1.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Cote d'Ivoire ahead.
Burkina Faso ranks 73rd and Cote d'Ivoire ranks 72nd of 141 countries.
Across the 3 decades both report, Burkina Faso averaged higher in 2 and Cote d'Ivoire in 1.
Head to head by decade
| Decade | Burkina Faso | Cote d'Ivoire | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.1% | 3.4% | 5.7% | Burkina Faso |
| 2010s | 40.3% | 28.6% | 11.7% | Burkina Faso |
| 2020s | 60.8% | 61.2% | 0.4% | Cote d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Burkina Faso or Cote d'Ivoire?
- Cote d'Ivoire, at 69.0% against 68.0% in Burkina Faso as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Burkina Faso and Cote d'Ivoire?
- 1.0%, with Cote d'Ivoire ahead.
- How many years of comparable data are there for Burkina Faso and Cote d'Ivoire?
- 25 years are reported by both, from 2000 to 2024.
- How do Burkina Faso and Cote d'Ivoire rank globally for access to anti-retroviral drugs, male?
- Burkina Faso ranks 73rd and Cote d'Ivoire ranks 72nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.